Aymanshafei (Talk | contribs) |
Aymanshafei (Talk | contribs) |
||
Line 55: | Line 55: | ||
.nivo-directionNav .nivo-prevNav{ | .nivo-directionNav .nivo-prevNav{ | ||
− | background-image: url( | + | background-image: url(https://2017.igem.org/File:Circle-left.png); |
background-size: cover; | background-size: cover; | ||
text-indent: -9999px; | text-indent: -9999px; | ||
Line 62: | Line 62: | ||
.nivo-directionNav .nivo-nextNav{ | .nivo-directionNav .nivo-nextNav{ | ||
− | background-image: url( | + | background-image: url(https://2017.igem.org/File:Circle-right.png); |
background-size: cover; | background-size: cover; | ||
text-indent: -9999px; | text-indent: -9999px; |
Revision as of 23:56, 16 October 2017
Abstract
Knock-in of Circular RNA gene in Hepatocellular Carcinoma cells via CRISPR/Cas9
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers
in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-.
"Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique
that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma.
This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.
This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.